Fluconazole susceptibility testing of Candida inconspicua clinical isolates: comparison of four methods
Open Access
- 1 February 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (2) , 275-276
- https://doi.org/10.1093/jac/dkh539
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic ProceduresJournal of Clinical Microbiology, 2003
- Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of WarsawTransplantation Proceedings, 2003
- In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from BloodJournal of Clinical Microbiology, 2003
- In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.Journal of Antimicrobial Chemotherapy, 1999
- Candida inconspicua, a Fluconazole‐Resistant Pathogen in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1997